MY6100048A - Improvements in or relating to insulin preparations - Google Patents
Improvements in or relating to insulin preparationsInfo
- Publication number
- MY6100048A MY6100048A MY6100048A MY6100048A MY6100048A MY 6100048 A MY6100048 A MY 6100048A MY 6100048 A MY6100048 A MY 6100048A MY 6100048 A MY6100048 A MY 6100048A MY 6100048 A MY6100048 A MY 6100048A
- Authority
- MY
- Malaysia
- Prior art keywords
- relating
- insulin preparations
- insulin
- preparations
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK840870X | 1957-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY6100048A true MY6100048A (en) | 1961-12-31 |
Family
ID=8153224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MY6100048A MY6100048A (en) | 1957-08-03 | 1961-12-31 | Improvements in or relating to insulin preparations |
Country Status (3)
| Country | Link |
|---|---|
| CY (1) | CY217A (en) |
| GB (1) | GB840870A (en) |
| MY (1) | MY6100048A (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3228320T (en) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combination of an insulin and a glp-1 agonist |
| JP5832439B2 (en) | 2009-11-13 | 2015-12-16 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Pharmaceutical composition comprising a GLP-1 agonist, insulin and methionine |
| SG10201500871TA (en) | 2009-11-13 | 2015-04-29 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
| CN103179978A (en) | 2010-08-30 | 2013-06-26 | 赛诺菲-安万特德国有限公司 | Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| TWI780236B (en) | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| KR20160104726A (en) * | 2014-01-09 | 2016-09-05 | 사노피 | Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives |
| CA2932873A1 (en) | 2014-01-09 | 2015-07-16 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
| JP6641280B2 (en) | 2014-01-09 | 2020-02-05 | サノフイＳａｎｏｆｉ | Stabilized pharmaceutical formulations of insulin analogues and / or insulin derivatives |
| CN107206058A (en) | 2014-12-12 | 2017-09-26 | 赛诺菲-安万特德国有限公司 | Insulin glargine/lixisenatide fixed ratio preparaton |
| TWI748945B (en) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | Treatment type 2 diabetes mellitus patients |
| TW201705975A (en) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | Treatment of type 2 diabetes mellitus patients |
-
1958
- 1958-07-15 GB GB22705/58A patent/GB840870A/en not_active Expired
-
1961
- 1961-03-27 CY CY21761A patent/CY217A/en unknown
- 1961-12-31 MY MY6100048A patent/MY6100048A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY217A (en) | 1961-03-27 |
| GB840870A (en) | 1960-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY217A (en) | Improvements in or relating to insulin preparations | |
| GB821574A (en) | Improvements in or relating to dust-separators | |
| MY6600043A (en) | Improvements in or relating to containers | |
| CY234A (en) | Improvements in or relating to insulin preparations | |
| CY216A (en) | Improvements in or relating to insulin preparations | |
| AU220470B2 (en) | Improvements in or relating to medicinal preparations | |
| GB870992A (en) | Improvements in or relating to powered loaders | |
| AU3204957A (en) | Improvements in or relating to medicinal preparations | |
| AU216717B2 (en) | Improvements in or relating to lipsticks | |
| AU221884B2 (en) | Improvements in or relating to bottlecaps | |
| AU221593B2 (en) | Improvements in or relating to pushcarts | |
| AU221661B2 (en) | Improvements in or relating to spark-machining | |
| AU221677B2 (en) | Improvements in or relating to spark-machining | |
| AU223641B2 (en) | Improvements in or relating to light-fittings | |
| GB821919A (en) | Improvements in or relating to pulverisers | |
| AU222961B2 (en) | Improvements in or relating to chairs | |
| IE23675L (en) | Insulin preparations | |
| AU226465B2 (en) | Improvements in and relating to transdurers | |
| AU224855B2 (en) | Improvements in or relating to brooders | |
| AU2719257A (en) | Improvements in or relating to lipsticks | |
| AU2673957A (en) | Improvements in or relating to pushcarts | |
| AU2577557A (en) | Improvements in or relating to spark-machining | |
| AU2711557A (en) | Improvements in or relating to bottlecaps | |
| AU2714957A (en) | Improvements in or relating to spark-machining | |
| AU3303957A (en) | Improvements in or relating to light-fittings |